Patents by Inventor Conrad Gerard SCHWARZER

Conrad Gerard SCHWARZER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10576052
    Abstract: The present invention refers to a glycerol ester composition comprising glyceryl monovalerate, for use in preventing and/or alleviating bacterial inflammation in a monogastric animal (including human) by inhibiting the adhesion of pathogenic bacteria to the intestinal lumen of said animal. The present invention also refers to a therapeutic method for promoting the renewal and growth of epithelial cells in the small intestine of a monogastric animal (including human), the method comprising the step of distributing a glycerol ester composition comprising glyceryl monovalerate to said animal.
    Type: Grant
    Filed: November 10, 2016
    Date of Patent: March 3, 2020
    Assignee: PERSTORP AB
    Inventors: Filip Van Immerseel, Karolien Van Driessche, Richard Ducatelle, Conrad Gerard Schwarzer
  • Patent number: 10420745
    Abstract: The present invention refers to a glycerol ester composition comprising the reaction product obtained from reacting valeric acid and glycerol at a molar ratio of between 1:0.8 and 1:1.2, for use in reduction and/or inhibition of the growth of gram-positive, pathogenic bacteria. The present invention also refers to said glycerol ester composition for use in prevention and/or alleviation of necrotic enteritis in the gastric tract of galloanserans.
    Type: Grant
    Filed: March 17, 2016
    Date of Patent: September 24, 2019
    Assignee: PERSTORP AB
    Inventors: Filip Van Immerseel, Karolien Van Driessche, Richard Ducatelle, Conrad Gerard Schwarzer
  • Publication number: 20180353456
    Abstract: The present invention refers to a glycerol ester composition comprising glyceryl monovalerate, for use in preventing and/or alleviating bacterial inflammation in a monogastric animal (including human) by inhibiting the adhesion of pathogenic bacteria to the intestinal lumen of said animal. The present invention also refers to a therapeutic method for promoting the renewal and growth of epithelial cells in the small intestine of a monogastric animal (including human), the method comprising the step of distributing a glycerol ester composition comprising glyceryl monovalerate to said animal.
    Type: Application
    Filed: November 10, 2016
    Publication date: December 13, 2018
    Inventors: Filip VAN IMMERSEEL, Karolien VAN DRIESSCHE, Richard DUCATELLE, Conrad Gerard SCHWARZER
  • Publication number: 20180071241
    Abstract: The present invention refers to a glycerol ester composition comprising the reaction product obtained from reacting valeric acid and glycerol at a molar ratio of between 1:0.8 and 1:1.2, for use in reduction and/or inhibition of the growth of gram-positive, pathogenic bacteria. The present invention also refers to said glycerol ester composition for use in prevention and/or alleviation of necrotic enteritis in the gastric tract of galloanserans.
    Type: Application
    Filed: March 17, 2016
    Publication date: March 15, 2018
    Applicant: PERSTORP AB
    Inventors: Filip VAN IMMERSEEL, Karolien VAN DRIESSCHE, Richard DUCATELLE, Conrad Gerard SCHWARZER
  • Patent number: 9877945
    Abstract: The present invention refers to the use of a glycerol ester composition of at least one short chain fatty acid for preventing and/or alleviating necrotic enteritis in the gastric tract of galloanserans. The glycerol ester composition comprises at least 75% by weight of glyceryl tributyrate, below 25% by weight of glyceryl dibutyrate and below 8% by weight of glyceryl monobutyrate. The present invention also refers to the use of the glycerol ester composition for modulating the gut flora of galloanserans.
    Type: Grant
    Filed: September 30, 2016
    Date of Patent: January 30, 2018
    Assignee: PERSTORP AB
    Inventors: Filip Van Immerseel, Richard Sygall, Karolien Van Driessche, Richard Ducatelle, Conrad Gerard Schwarzer
  • Publication number: 20170087115
    Abstract: The present invention refers to the use of a glycerol ester composition of at least one short chain fatty acid for preventing and/or alleviating necrotic enteritis in the gastric tract of galloanserans. The glycerol ester composition comprises at least 75% by weight of glyceryl tributyrate, below 25% by weight of glyceryl dibutyrate and below 8% by weight of glyceryl monobutyrate. The present invention also refers to the use of the glycerol ester composition for modulating the gut flora of galloanserans.
    Type: Application
    Filed: September 30, 2016
    Publication date: March 30, 2017
    Applicant: PERSTORP AB
    Inventors: Filip Van IMMERSEEL, Richard SYGALL, Karolien Van DRIESSCHE, Richard DUCATELLE, Conrad Gerard SCHWARZER
  • Publication number: 20160256426
    Abstract: The present invention refers to the use of a glycerol ester composition of at least one short chain fatty acid for preventing and/or alleviating necrotic enteritis in the gastric tract of galloanserans. The glycerol ester composition comprises at least 75% by weight of glyceryl tributyrate, below 25% by weight of glyceryl dibutyrate and below 8% by weight of glyceryl monobutyrate. The present invention also refers to the use of said composition for modulating the gut flora of galloanserans.
    Type: Application
    Filed: October 6, 2014
    Publication date: September 8, 2016
    Applicant: Perstorp AB
    Inventors: Filip Van IMMERSEEL, Richard SYGALL, Karolien Van DRIESSCHE, Richard DUCATELLE, Conrad Gerard SCHWARZER